Silvia Carluccio

发表

Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study

L. Nencioni, A. Palamara, R. Scrivo, 2013, Virology Journal.

Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors

J. Jukema, P. Quax, J. Jukema, 2012, Journal of cellular and molecular medicine.

Generation of tumor‐specific cytotoxic T‐lymphocytes from the peripheral blood of colorectal cancer patients for adoptive T‐cell transfer

E. Setola, P. Ferrante, S. Delbue, 2015, Journal of cellular physiology.

A Potential Linkage Between the JC and BK Polyomaviruses and Brain and Urinary Tract Tumors: A Review of the Literature

P. Ferrante, S. Delbue, S. Carluccio, 2014 .

Evidence supporting the association of polyomavirus BK genome with prostate cancer

P. Ferrante, S. Delbue, S. Carluccio, 2013, Medical Microbiology and Immunology.

A Review on JC Virus Infection in Kidney Transplant Recipients

A. Edefonti, P. Ferrante, S. Delbue, 2013, Clinical & developmental immunology.

The long and evolving relationship between viruses and multiple sclerosis

P. Ferrante, S. Delbue, S. Carluccio, 2012 .

Investigation of polyomaviruses replication in pediatric patients with nephropathy receiving rituximab

S. Dallari, P. Ferrante, S. Delbue, 2012, Journal of medical virology.

Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab

R. Bergamaschi, S. Dallari, P. Ferrante, 2015, Journal of Neuroimmunology.

JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy

R. Maserati, E. Marchioni, P. Ferrante, 2012, Journal of cellular physiology.

Interaction Between Human Polyomavirus BK and Hypoxia Inducible Factor‐1 alpha

P. Ferrante, S. Delbue, R. Boldorini, 2016, Journal of cellular physiology.

JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients

R. Bergamaschi, P. Ferrante, S. Delbue, 2015, Journal of NeuroVirology.

JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients

R. Bergamaschi, P. Ferrante, S. Delbue, 2014, Journal of NeuroVirology.

Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study

L. Nencioni, A. Palamara, R. Scrivo, 2013, Virology Journal.